Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kerry Wall"'
Autor:
Maria Z. Ahmed, Indrani Venkatadasari, Sara Dyer, Kerry Wall, Emma Huxley, Richard Lovell, Bhuvan Kishore, Hansini Dassanayake, Sebastian Francis, Emmanouil Nikolousis, Alexandros Kanellopoulos
Publikováno v:
Annals of Hematology. 101:2553-2554
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fbe54883860ade5aff79598d2d30ba
https://doi.org/10.1007/s00277-022-04941-5
https://doi.org/10.1007/s00277-022-04941-5
Autor:
Duncan Murray, Paul Moss, Mike Griffiths, Ram Malladi, Kerry Wall, Kathy Holder, Emmanouil Nikolousis, Yuen T Chan, Francesca A M Kinsella, Charles Craddock, Graham McIlroy, Charlotte F. Inman, Amy Gudger, Jianmin Zuo, Jane Nunnick, Sandeep Nagra
Publikováno v:
Leukemia research. 83
Background The importance of chimerism status in the very early period after hematopoietic stem cell transplantation is unclear. We determined PBMC and T-cell donor chimerism 50 days after transplantation and related this to disease relapse and overa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38e031dbf5344ed9ef7dfcb22113ed6
https://pubmed.ncbi.nlm.nih.gov/31276965
https://pubmed.ncbi.nlm.nih.gov/31276965
Autor:
Rosemary E. Gale, Neesa Bhudia, Kerry Wall, Frank McCaughan, Hassan Farah, Alan Kenneth Burnett, Michael A. Simpson, Jelena V. Jovanovic, Paresh Vyas, David Grimwade, Robert Kerrin Hills, Amanda F. Gilkes, Yashma Patel, Susanna Akiki, Ellen Solomon, Joanne Mason, Sylvie D. Freeman, David C. Linch, Adam Ivey, Angela Grech, Nigel H. Russell, Mike Griffiths
Publikováno v:
Ivey, A, Hills, R K, Simpson, M A, Jovanovic, J V, Gilkes, A, Grech, A, Patel, Y, Bhudia, N, Farah, H, Mason, J, Wall, K, Akiki, S, Griffiths, M, Solomon, E, McCaughan, F, Linch, D C, Gale, R E, Vyas, P, Freeman, S D, Russell, N, Burnett, A K & Grimwade, D 2016, ' Assessment of minimal residual disease in standard-risk AML ', New England Journal of Medicine, vol. 374, no. 5, pp. 422-433 . https://doi.org/10.1056/NEJMoa1507471
Despite the molecular heterogeneity of standard-risk acute myeloid leukemia (AML), treatment decisions are based on a limited number of molecular genetic markers and morphology-based assessment of remission. Sensitive detection of a leukemia-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba54f009593e6cccd0bc0f0861d20b4
https://kclpure.kcl.ac.uk/ws/files/46993158/nejmoa1507471.pdf
https://kclpure.kcl.ac.uk/ws/files/46993158/nejmoa1507471.pdf
Publikováno v:
Brain. 130:836-842
Haemangioblastomas of the CNS are a cardinal feature of von Hippel-Lindau (VHL) disease, a dominantly inherited multisystem familial cancer syndrome caused by germline mutation of the VHL tumour suppressor gene. We investigated the frequency of VHL m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5005ed89764a9b23806704eda8995510
https://doi.org/10.1093/brain/awl362
https://doi.org/10.1093/brain/awl362
Autor:
Shamyla Siddique, Manoj Raghavan, Charles Craddock, Lynn Quek, Steven Knapper, Adam Ivey, Anna Schuh, Nicolas Goardon, Andrew Price, Mike Griffiths, A. Aztberger, Kerry Wall, Paul Virgo, Ravindra Majeti, Sylvie D. Freeman, Robert Kerrin Hills, Julie Arrazi, Tina McSkeane, Benjamin Davies, James D. Cavenagh, David Grimwade, Alan Kenneth Burnett, Paresh Vyas, Irving L. Weissman, Cassandra Brookes
Publikováno v:
Leukemia. 27(5)
Epigenetic therapies demonstrate significant clinical activity in acute myeloid leukemia (AML) and myelodysplasia (MDS) and constitute an important new class of therapeutic agents. However hematological responses are not durable and disease relapse a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a101a133155936ca71b83ec225eab5
http://ora.ox.ac.uk/objects/uuid:98e893bf-0354-4370-926d-b3c90276a781
http://ora.ox.ac.uk/objects/uuid:98e893bf-0354-4370-926d-b3c90276a781
Autor:
Nigel H. Russell, David Grimwade, Neesa Bhudia, Susanna Akiki, Rosemary E. Gale, Amanda F. Gilkes, Kerry Wall, Hassan Farah, Alan Kenneth Burnett, Sylvie D. Freeman, Frank McCaughan, Jelena V. Jovanovic, Paresh Vyas, Robert Kerrin Hills, Joanne Mason, Adam Ivey, Yashma Patel, Ellen Solomon, David C. Linch, Michael A. Simpson
Publikováno v:
Blood. 124:70-70
NPM1 mutation (NPM1c) defines the commonest molecular subtype of AML, which is molecularly heterogeneous, with outcome influenced by the pattern of cooperating mutations. This has generated interest in molecular profiling to guide treatment approach,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45b34e37e14bf72d0a8cb227c9a2c79f
https://doi.org/10.1182/blood.v124.21.70.70
https://doi.org/10.1182/blood.v124.21.70.70
Autor:
Charles Craddock, Francesca A M Kinsella, Emmanouil Nikolousis, Amy Gudger, Ram Malladi, Charlotte F. Inman, Michael J. Griffiths, Paul Moss, Graham Mc Ilroy, Sandeep Nagra, Jane Nunnick, Kerry Wall, Dave Waldron
Publikováno v:
Blood. 124:423-423
The significance of mixed donor chimerism as a hallmark of an unsuccessful graft versus leukaemia effect and disease relapse is unclear. Whilst some studies have described changes in PBMC and T cell chimerism that may predict relapse, patients at hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ec3ac66a07736103c4cd88a883052cd
https://doi.org/10.1182/blood.v124.21.423.423
https://doi.org/10.1182/blood.v124.21.423.423